Loading organizations...
Biotechnology company developing precision medicines for human disease.
MOMA Therapeutics was founded by Johannes Walter (Founder) and Timur Yusufzai (Co-Founder) and Eva Nogales (Founder) and Dorothee Kern (Founder).
MOMA Therapeutics has raised $150.0M in total across 1 funding round.
MOMA Therapeutics was founded by Johannes Walter (Founder) and Timur Yusufzai (Co-Founder) and Eva Nogales (Founder) and Dorothee Kern (Founder).
MOMA Therapeutics has raised $150.0M in total across 1 funding round.
MOMA Therapeutics's investors include Amit Sinha, Alexandria Venture Investments, Casdin Capital, Cormorant Asset Management, Creacion Ventures, Invus, LifeSci Venture Partners, MOMA Therapeutics, Nextech Invest, Pavilion Capital, Rock Springs Capital, Section 32.
Key people at MOMA Therapeutics.
MOMA Therapeutics has raised $150.0M across 1 funding round. Most recently, it raised $150.0M Series B in May 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 10, 2022 | MOMA Therapeutics | $150.0M Series B | Amit Sinha, Amit Sinha | Alexandria Venture Investments, Casdin Capital, Cormorant Asset Management, Creacion Ventures, Invus, LifeSci Venture Partners, Nextech Invest, Pavilion Capital, Rock Springs Capital, Section 32, Third Rock Ventures |
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 10, 2022 | $150.0M Series B | Amit Sinha, Amit Sinha | Alexandria Venture Investments, Casdin Capital, Cormorant Asset Management, Creacion Ventures, Invus, LifeSci Venture Partners, MOMA Therapeutics, Nextech Invest, Pavilion Capital, Rock Springs Capital, Section 32, Third Rock Ventures |